Everolimus-Eluting Platinum Chromium Coronary Stent System

Outstanding Clinical Outcomes

Platinum Chromium Everolimus-Eluting Clinical Experience.

Excellent Safety and Performance with Promus PtCr EES1

  • Over 10,000 Patients Studied
  • Over 1 Million Implants

The Promus PREMIERTM Stent is the newest member of the PROMUSTMfamily, featuring the same low dose Everolimus drug and PVDF-HFP polymer combined with the exceptional Platinum Chromium platform. The PLATINUM Clinical Trial Program is the basis for the Promus PREMIER Stent System approval.

Outstanding Clinical Outcomes
Outstanding Clinical Outcomes

PREMIER Architecture.
PREMIER Outcomes.

Features the only customized Platinum Chromium Stent architecture, the market-leading Everolimus drug and PVDF-HFP polymer combination and an enhanced catheter to provide Premier outcomes.